First AD

Second AD

Impact of IgAN on Quality of Life

From a patient’s perspective, what is the typical impact of IgA nephropathy on quality of life, both physically and emotionally?

Videos

Video Series

Peer Exchange

HCPLive® Peer Exchange panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's care professionals.

Advancing IgAN Care: Exploring the Next Wave of Treatments

IgA nephropathy significantly affects patients' quality of life, both physically and emotionally. Physically, patients often experience fatigue, hypertension, and edema, which can limit daily activities and overall physical functioning. Emotionally, the chronic nature of the disease, coupled with the uncertainty of progression to end-stage renal disease, can lead to anxiety, depression, and stress. The need for ongoing medical management and potential lifestyle changes further contributes to the emotional burden. Social interactions and work-life balance may also be disrupted, exacerbating the psychological impact.

Panelists discuss how IgA nephropathy affects patients’ quality of life, addressing both the physical symptoms and the emotional challenges associated with the condition.

Overview of IgAN and Its Common Symptoms

IgAN Progression

IgAN vs Other Glomerular Diseases

Biomarkers for IgAN

Genetic Screening for IgAN

Misdiagnosis and Barriers to Early Detection of IgAN

Differential Diagnoses of IgAN

Significance of Proteinuria for Potential IgAN

Proteinuria Variability and IgAN Diagnosis

Biomarkers and Improving IgAN Diagnostic Accuracy

Primary Treatment Goals for Patients With IgAN

Proteinuria Reduction in Long-Term Kidney Damage Prevention

Symptoms Management and Targeting the Root Cause of IgAN